日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer

奥拉帕尼联合度伐利尤单抗治疗转移性去势抵抗性前列腺癌患者的II期研究

Li, Chennan; Madan, Ravi A; Lee, Min-Jung; Lee, Sunmin; Sato, Nahoko; Rastogi, Shraddha; Shrestha, Roshan; Aragon-Ching, Jeanny B; Goswami, Meghali; Donahue, Renee N; Cordes, Lisa M; Baj, Anna; Seo, Clara C Y; Terrigino, Nicholas T; Bright, John R; Hennigan, S Thomas; King, Isaiah M; Trostel, Shana Y; Fenimore, John M; Liu, Yi; Calzone, Kathleen A; Schlom, Jeffrey; Gulley, James L; Dahut, William L; Figg, William D; Sowalsky, Adam G; Lee, Jung-Min; Karzai, Fatima

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer

针对错配修复功能正常的转移性结直肠癌的四重免疫疗法(QuICC)试验

Bracken-Clarke, Dara; Pastor, Danielle M; Marté, Jennifer L; Donahue, Renee N; Hodge, James W; Cordes, Lisa; Floudas, Charalampos S; Tschernia, Nicholas P; Karzai, Fatima; Brownell, Isaac; Turkbey, Evrim B; Soon-Shiong, Patrick; Schlom, Jeffrey; Gulley, James L; Maeng, Hoyoung M; Strauss, Julius; Redman, Jason M

A phase 2 study of GI-6207 in patients with recurrent medullary thyroid cancer

GI-6207治疗复发性甲状腺髓样癌患者的II期研究

Del Rivero, Jaydira; Donahue, Renee N; Marte, Jennifer L; Gramza, Ann; Bilusic, Marijo; Cordes, Lisa; Karzai, Fatima; Schlom, Jeffery; Gulley, James L; Madan, Ravi A

QTc measurement using Apple Watch electrocardiogram in congenital long QT syndrome

使用 Apple Watch 心电图测量先天性长 QT 综合征的 QTc 间期

van Steijn, Nicole J; Bergeman, Auke T; van der Werf, Christian; Veenstra, Renee N A M; van de Vijver, Willem R; Helmink, Ole G; Somsen, G Aernout; Tulevski, Igor I; Knops, Reinoud E; Wilde, Arthur A M; Winter, Michiel M

Occupational exposure to welding fume in Australian workplaces

澳大利亚工作场所中焊接烟尘的职业暴露

Driscoll, Tim R; Paine, Scott; Fritschi, Lin; Nguyen, Ha; Carey, Renee N

Tumor-Targeted IL-12 (PDS01ADC) with Hepatic Artery Infusion Pump Therapy for Colorectal Liver Metastases: Interim Analysis of a Non-randomized Phase II Trial

肿瘤靶向IL-12(PDS01ADC)联合肝动脉输注泵治疗结直肠癌肝转移:一项非随机II期试验的中期分析

Eade, Alyssa V; Smith, Emily C; Monge, Cecilia; Hannah, Cathleen E; Skorupan, Nebojsa; Hrones, Donna M; Celades, Carolina; Goswami, Meghali; Bagheri, Hana; Smith, Kathleen M; Rainey, Ashley J; Friedman, Lindsay R; Larrain, Carolina; Pu, Tracey; Sinha, Surajit; Desai, Priyanka P; Remmer, Kirsten; Satterwhite, Audra A; Joyce, Stacy R; Dinerman, Aaron J; Wood, Bradford J; Kassin, Michael T; Ukeh, Ifechi N; Blakely, Andrew M; Davis, Jeremy L; Kleiner, David E; Lassoued, Wiem; Gameiro, Sofia R; Donahue, Renee N; Gulley, James L; Schlom, Jeffrey; Hernandez, Jonathan M

A Content Analysis of Alcohol Marketing on Instagram: Examining Its Contribution to an Australian Aquatic Alcogenic Environment

对 Instagram 上酒精营销的内容分析:探究其对澳大利亚水生酒精环境的影响

Crawford, Gemma; Carey, Renee N; D'Orazio, Nicola; Jancey, Jonine; Leavy, Justine E

Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial

新型联合免疫疗法在HPV相关癌症患者中的临床疗效:一项非随机临床试验

Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Cordes, Lisa M; Steinberg, Seth M; Manu, Michell; Francis, Deneise C; Lamping, Elizabeth; Marté, Jennifer L; Kackley, Mary; Krauss, Elizabeth; Manukyan, Manuk; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L; Strauss, Julius

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

将靶向内源性逆转录病毒包膜蛋白ERVMER34-1的治疗性癌症疫苗与免疫肿瘤药物联合使用,可促进新表位特异性T细胞的扩增并增强肿瘤控制。

Maldonado, Maria Del Mar; Gracia-Hernandez, Maria; Le, Loc Huu; Iida, Masafumi; Gulley, James L; Donahue, Renee N; Palena, Claudia; Schlom, Jeffrey; Hamilton, Duane H

Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy

血清分析物作为预测三阴性乳腺癌患者疾病复发和无侵袭性疾病生存期的指标,这些患者均参与了 OXEL 试验,接受了免疫疗法、化疗或化疗联合免疫疗法治疗。

Toney, Nicole J; Lynch, Megan T; Lynce, Filipa; Mainor, Candace; Isaacs, Claudine; Schlom, Jeffrey; Donahue, Renee N